- Report
- December 2022
- 186 Pages
Europe
From €3098EUR$3,450USD£2,638GBP
- Report
- August 2022
- 210 Pages
Global
From €3995EUR$4,450USD£3,402GBP
- Report
- June 2024
- 200 Pages
Global
From €7138EUR$7,950USD£6,079GBP
- Report
- June 2024
- 180 Pages
Global
From €7138EUR$7,950USD£6,079GBP
- Report
- March 2024
- 134 Pages
Global
From €7138EUR$7,950USD£6,079GBP
- Report
- January 2024
- 175 Pages
Global
From €8530EUR$9,500USD£7,264GBP
- Report
- May 2023
- 450 Pages
Global
From €4489EUR$5,000USD£3,823GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2469EUR$2,750USD£2,103GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2469EUR$2,750USD£2,103GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2469EUR$2,750USD£2,103GBP
- Report
- September 2022
- 141 Pages
Global
From €3547EUR$3,950USD£3,020GBP
- Report
- February 2024
- 172 Pages
Global
From €3434EUR$3,825USD£2,925GBP
€4040EUR$4,500USD£3,441GBP
- Report
- September 2022
- 283 Pages
Global
From €6734EUR$7,500USD£5,735GBP
- Report
- May 2024
- 169 Pages
Global
From €2245EUR$2,500USD£1,912GBP
- Report
- February 2024
- 120 Pages
Global
From €4265EUR$4,750USD£3,632GBP
- Report
- April 2023
- 115 Pages
Global
From €4265EUR$4,750USD£3,632GBP
- Report
- August 2022
- 120 Pages
Global
From €4265EUR$4,750USD£3,632GBP
- Report
- January 2022
- 120 Pages
Global
From €4265EUR$4,750USD£3,632GBP
- Report
- May 2024
- 124 Pages
Global
From €3547EUR$3,950USD£3,020GBP
- Report
- May 2024
- 200 Pages
Global
From €3726EUR$4,150USD£3,173GBP

The Immunoglobulin market is a segment of the Immune Disorders Drugs market, which focuses on treatments for conditions related to the immune system. Immunoglobulin (Ig) is a type of protein found in the blood that helps fight infection and disease. It is used to treat a variety of immune-related conditions, including autoimmune diseases, allergies, and infections. Immunoglobulin therapies are typically administered intravenously or subcutaneously, and can be used to replace or supplement the body's natural Ig production.
The Immunoglobulin market is highly competitive, with a number of companies offering a range of products. These products vary in terms of dosage, delivery method, and cost. Companies in the market are focused on developing new therapies and improving existing ones, as well as expanding their product portfolios.
Some of the major companies in the Immunoglobulin market include CSL Behring, Grifols, Kedrion, Octapharma, and Shire. Show Less Read more